SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A Randomized Controlled Crossover Study

To evaluate the effect of spironolactone, a mineralocorticoid receptor antagonist, for nonresolving central serous chorioretinopathy. METHODS: This is a prospective, randomized, double-blinded, placebo-controlled crossover study. Sixteen eyes of 16 patients with central serous chorioretinopathy and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Retina
Main Authors: Bousquet, Elodie, Beydoun, Talal, Rothschild, Pierre-Raphaël, Bergin, Ciara, Zhao, Min, Batista, Rui, Brandely, Marie-Laure, Couraud, Benedicte, Farman, Nicolette, Gaudric, Alain, Chast, François, Behar-Cohen, Francine
Formato: Artigo
Idioma:Inglês
Publicado em: Retina 2015
Assuntos:
Original Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4697359/
https://ncbi.nlm.nih.gov/pubmed/26017871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000000614
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados